Aggregation is a major cause of the misbehavior of proteins. A system for modifying a protein to create a more stable variant is provided. The method involves identifying non-conserved hydrophobic amino acid residues on the surface of a protein, suitable for mutating to more hydrophilic residues (e.
Aggregation is a major cause of the misbehavior of proteins. A system for modifying a protein to create a more stable variant is provided. The method involves identifying non-conserved hydrophobic amino acid residues on the surface of a protein, suitable for mutating to more hydrophilic residues (e.g., charged amino acids). Any number of residues on the surface may be changed to create a variant that is more soluble, resistant to aggregation, has a greater ability to re-fold, and/or is more stable under a variety of conditions. The invention also provides GFP, streptavidin, and GST variants with an increased theoretical net charge created by the inventive technology. Kits are also provided for carrying out such modifications on any protein of interest.
대표청구항▼
1. A method of improving the stability of a protein of interest, the method comprising steps of: (1) identifying non-conserved surface residues of a protein of interest by comparing the amino acid sequence of the protein with at least one other amino acid sequence of the protein from the same protei
1. A method of improving the stability of a protein of interest, the method comprising steps of: (1) identifying non-conserved surface residues of a protein of interest by comparing the amino acid sequence of the protein with at least one other amino acid sequence of the protein from the same protein family or a different species, wherein a residue is non-conserved if less than or equal to 50% of the amino acid sequences have the same amino acid sequence in a particular position; and(2) replacing a plurality of non-conserved, surface residues identified in step (1) with a natural amino acid residue that is positively charged at physiological pH, whereby the method creates a modified protein of interest having a theoretical net charge of at least about +10 at physiological pH as compared to the theoretical net charge of the original protein of interest. 2. A method of improving the stability of a protein of interest, the method comprising steps of: (1) identifying non-conserved surface residues of a protein of interest by comparing the amino acid sequence of the protein with at least one other amino acid sequence of the protein from the same protein family or a different species, wherein a residue is non-conserved if less than or equal to 50% of the amino acid sequences have the same amino acid sequence in a particular position; and(2) replacing a plurality of non-conserved, surface residues identified in step (1) with a natural amino acid residue that is negatively charged at physiological pH, whereby the method creates a modified protein of interest having a theoretical net charge of less than about −10 at physiological pH as compared to the theoretical net charge of the original protein of interest. 3. A method of improving the stability of a protein of interest, the method comprising steps of: (1) identifying non-conserved surface residues of the protein of interest by comparing the amino acid sequence of the protein with at least one other amino acid sequence of the protein from the same protein family or a different species, wherein a residue is non-conserved if less than or equal to 50% of the amino acid sequences have the same amino acid sequence in a particular position;(2) assigning a hydrophobicity value to each of the identified non-conserved surface residues; and(3) replacing at least one surface residue with a natural amino acid residue that is charged at physiological pH, wherein the residues being replaced are all mutated into the same type of residue, wherein the type of residue is either positively charged residues or negatively charged residues; and(4) creating a modified protein of interest having a theoretical net charge of at least about +10 or less than about −10 at physiological pH as compared to the theoretical net charge of the original protein of interest. 4. The method of claim 3, wherein the step of replacing comprises replacing at least one hydrophobic surface residue. 5. The method of claim 3, wherein the step of replacing comprises replacing at least one hydrophilic surface residue. 6. The method of claim 3, wherein the step of replacing comprises replacing at least one charged surface residue. 7. The method of claim 3, wherein the step of replacing comprises replacing at least one surface residue with a lysine residue. 8. The method of claim 3, wherein the step of replacing comprises replacing at least one surface residue with an aspartate or glutamate residue. 9. The method of claim 3, wherein the step of replacing comprises replacing at least five surface residues. 10. The method of claim 3, wherein the step of replacing comprises replacing at least ten surface residues. 11. The method of claim 3, wherein the step of replacing comprises replacing at least twenty surface residues. 12. The method of claim 3, wherein the step of replacing comprises replacing at least thirty surface residues. 13. The method of claim 3, whereby the method creates a modified protein with a greater net charge at physiological pH than the original protein of interest. 14. The method of claim 3, whereby the method creates a modified protein of interest that is more negatively charged at physiological pH than the original protein of interest. 15. The method of claim 3, whereby the method creates a modified protein of interest that is at least −10 more negatively charged at physiological pH than the original protein of interest. 16. The method of claim 3, whereby the method creates a modified protein of interest that is at least −15 more negatively charged at physiological pH than the original protein of interest. 17. The method of claim 3, whereby the method creates a modified protein of interest that is at least −20 more negatively charged at physiological pH than the original protein of interest. 18. The method of claim 3, whereby the method creates a modified protein of interest that is more positively charged at physiological pH than the original protein of interest. 19. The method of claim 3, whereby the method creates a modified protein of interest that is at least +10 more positively charged at physiological pH than the original protein of interest. 20. The method of claim 3, whereby the method creates a modified protein of interest that is at least +15 more positively charged at physiological pH than the original protein of interest. 21. The method of claim 3, whereby the method creates a modified protein of interest that is at least +20 more positively charged at physiological pH than the original protein of interest. 22. The method of claim 3, wherein the step of assigning a hydrophobicity value comprises using octanol/water P values. 23. The method of claim 3, wherein the step of replacing comprises mutagenizing the sequence of the protein to replace the identified hydrophobic and non-conserved surface residue with a natural amino acid residue that is charged at physiological pH. 24. The method of claim 23, wherein the natural amino acid residue is selected from the group consisting of lysine, glutamate, aspartate, histidine, and arginine. 25. The method of claim 23, wherein the natural amino acid residue is selected from the group consisting of lysine, histidine, and arginine. 26. The method of claim 23, wherein the natural amino acid residue is lysine. 27. The method of claim 23, wherein the natural amino acid residue is selected from the group consisting of glutamate and aspartate. 28. The method of claim 3, wherein the step of replacing comprises site-directed mutagenesis of the identified non-conserved surface residues. 29. The method of claim 3, wherein the step of replacing comprises PCR mutagenesis of the identified non-conserved surface residues. 30. The method of claim 1, wherein the step of replacing comprises replacing at least five surface residues. 31. The method of claim 1, wherein the step of replacing comprises replacing at least ten surface residues. 32. The method of claim 1, wherein all the residues being replaced are changed into the same residue. 33. The method of claim 1, wherein the residues being replaced are changed into different residues. 34. The method of claim 3, wherein all the residues being replaced are changed into the same residue. 35. The method of claim 3, wherein the residues being replaced are changed into different residues.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (39)
Cook Phillip Dan ; Manoharan Muthiah ; Kawasaki Andrew Mamoru, 2'-O-aminooxy-modified oligonucleotides.
Arimilli Murty N. ; Cundy Kenneth C. ; Dougherty Joseph P. ; Kim Choung U. ; Oliyai Reza ; Stella Valentino J., Antiviral phosphonomethoxy nucleotide analogs having increased oral bioavailability.
Hubbard Vance M. (Bedford) Brunson Welton K. (Bedford) Saied V. C. (Wichita Falls TX), Apparatus and method for raising a skin wheal and anesthetizing skin.
Lilley Stephen J. (Sawston GBX) Taylor Hugh F. (Sawston GBX) Theobald David R. (Huntingdon GBX) Carlson Craig J. (Andover MA) Rosen David I. (Arlington MA) Johnson Thomas R. (Milford NH), Medical injection system and method, gas spring thereof and launching device using gas spring.
McKinnon ; Jr. Charles N. (Laguna Niguel CA) Peterson Steven F. (West Linn OR) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection device.
Peterson Steven F. (West Linn OR) McKinnon ; Jr. Charles N. (Laguna Niguel CA) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection methods and device.
Bischofberger Norbert W. ; Jones Robert J. ; Arimilli Murty N. ; Lin Kuei-Ying ; Louie Michael S. ; McGee Lawrence R. ; Prisbe Ernest J. ; Lee William A. ; Cundy Kenneth C., Nucleotide analogs.
Yamada,Hidenori; Futami,Junichiro; Maeda,Takashi; Kitazoe,Midori; Nakanishi,Hidetaka, Test kit for intracellular introduction of protein and/or peptide and method of intracellular introduction.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.